Cargando…

Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors

As a result of the ring-into-ring conversion of nitrosoimidazole derivatives, we obtained a molecular scaffold that, when properly decorated, is able to decrease inotropy by blocking L-type calcium channels. Previously, we used this scaffold to develop a quantitative structure-activity relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinelli, Domenico, Budriesi, Roberta, Cosimelli, Barbara, Severi, Elda, Micucci, Matteo, Baroni, Massimo, Fusi, Fabio, Ioan, Pierfranco, Cross, Simon, Frosini, Maria, Saponara, Simona, Matucci, Rosanna, Rosano, Camillo, Viale, Maurizio, Chiarini, Alberto, Carosati, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271282/
https://www.ncbi.nlm.nih.gov/pubmed/25317581
http://dx.doi.org/10.3390/molecules191016543
_version_ 1783376892646129664
author Spinelli, Domenico
Budriesi, Roberta
Cosimelli, Barbara
Severi, Elda
Micucci, Matteo
Baroni, Massimo
Fusi, Fabio
Ioan, Pierfranco
Cross, Simon
Frosini, Maria
Saponara, Simona
Matucci, Rosanna
Rosano, Camillo
Viale, Maurizio
Chiarini, Alberto
Carosati, Emanuele
author_facet Spinelli, Domenico
Budriesi, Roberta
Cosimelli, Barbara
Severi, Elda
Micucci, Matteo
Baroni, Massimo
Fusi, Fabio
Ioan, Pierfranco
Cross, Simon
Frosini, Maria
Saponara, Simona
Matucci, Rosanna
Rosano, Camillo
Viale, Maurizio
Chiarini, Alberto
Carosati, Emanuele
author_sort Spinelli, Domenico
collection PubMed
description As a result of the ring-into-ring conversion of nitrosoimidazole derivatives, we obtained a molecular scaffold that, when properly decorated, is able to decrease inotropy by blocking L-type calcium channels. Previously, we used this scaffold to develop a quantitative structure-activity relationship (QSAR) model, and we used the most potent oxadiazolothiazinone as a template for ligand-based virtual screening. Here, we enlarge the diversity of chemical decorations, present the synthesis and in vitro data for 11 new derivatives, and develop a new 3D-QSAR model with recent in silico techniques. We observed a key role played by the oxadiazolone moiety: given the presence of positively charged calcium ions in the transmembrane channel protein, we hypothesize the formation of a ternary complex between the oxadiazolothiazinone, the Ca(2+) ion and the protein. We have supported this hypothesis by means of pharmacophore generation and through the docking of the pharmacophore into a homology model of the protein. We also studied with docking experiments the interaction with a homology model of P-glycoprotein, which is inhibited by this series of molecules, and provided further evidence toward the relevance of this scaffold in biological interactions.
format Online
Article
Text
id pubmed-6271282
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62712822018-12-27 Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors Spinelli, Domenico Budriesi, Roberta Cosimelli, Barbara Severi, Elda Micucci, Matteo Baroni, Massimo Fusi, Fabio Ioan, Pierfranco Cross, Simon Frosini, Maria Saponara, Simona Matucci, Rosanna Rosano, Camillo Viale, Maurizio Chiarini, Alberto Carosati, Emanuele Molecules Article As a result of the ring-into-ring conversion of nitrosoimidazole derivatives, we obtained a molecular scaffold that, when properly decorated, is able to decrease inotropy by blocking L-type calcium channels. Previously, we used this scaffold to develop a quantitative structure-activity relationship (QSAR) model, and we used the most potent oxadiazolothiazinone as a template for ligand-based virtual screening. Here, we enlarge the diversity of chemical decorations, present the synthesis and in vitro data for 11 new derivatives, and develop a new 3D-QSAR model with recent in silico techniques. We observed a key role played by the oxadiazolone moiety: given the presence of positively charged calcium ions in the transmembrane channel protein, we hypothesize the formation of a ternary complex between the oxadiazolothiazinone, the Ca(2+) ion and the protein. We have supported this hypothesis by means of pharmacophore generation and through the docking of the pharmacophore into a homology model of the protein. We also studied with docking experiments the interaction with a homology model of P-glycoprotein, which is inhibited by this series of molecules, and provided further evidence toward the relevance of this scaffold in biological interactions. MDPI 2014-10-14 /pmc/articles/PMC6271282/ /pubmed/25317581 http://dx.doi.org/10.3390/molecules191016543 Text en © 2014 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Spinelli, Domenico
Budriesi, Roberta
Cosimelli, Barbara
Severi, Elda
Micucci, Matteo
Baroni, Massimo
Fusi, Fabio
Ioan, Pierfranco
Cross, Simon
Frosini, Maria
Saponara, Simona
Matucci, Rosanna
Rosano, Camillo
Viale, Maurizio
Chiarini, Alberto
Carosati, Emanuele
Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors
title Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors
title_full Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors
title_fullStr Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors
title_full_unstemmed Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors
title_short Playing with Opening and Closing of Heterocycles: Using the Cusmano-Ruccia Reaction to Develop a Novel Class of Oxadiazolothiazinones, Active as Calcium Channel Modulators and P-Glycoprotein Inhibitors
title_sort playing with opening and closing of heterocycles: using the cusmano-ruccia reaction to develop a novel class of oxadiazolothiazinones, active as calcium channel modulators and p-glycoprotein inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271282/
https://www.ncbi.nlm.nih.gov/pubmed/25317581
http://dx.doi.org/10.3390/molecules191016543
work_keys_str_mv AT spinellidomenico playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT budriesiroberta playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT cosimellibarbara playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT severielda playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT micuccimatteo playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT baronimassimo playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT fusifabio playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT ioanpierfranco playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT crosssimon playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT frosinimaria playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT saponarasimona playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT matuccirosanna playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT rosanocamillo playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT vialemaurizio playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT chiarinialberto playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors
AT carosatiemanuele playingwithopeningandclosingofheterocyclesusingthecusmanorucciareactiontodevelopanovelclassofoxadiazolothiazinonesactiveascalciumchannelmodulatorsandpglycoproteininhibitors